Industry Research Reports

Home > Reports > Medical Care > Global Vaccinia Virus (VACV) Service Market Research Report 2024

Global Vaccinia Virus (VACV) Service Market Research Report 2024

Industry: Medical Care

Published: 2024-12-14

Pages: 78 Pages

Report ld: 3403912

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Vaccinia virus (VACV or VV) is the most widely used viral vector for the study of exogenous gene expression and immunogenicity of the resulting protein. Replication-competent recombinant VACV-based vaccines have received increasing attention as potential vaccine vectors for many infectious diseases, as they may be able to elicit potent humoral and cell-mediated immune responses and long-lasting protection.Vaccinia virus (VACV) is a large enveloped, double-stranded DNA virus in the genus of Orthopoxvirus of the family Poxviridae. The VACV genome is comprised of approximately 190,000 nucleotides which encodes approximately 250 genes. VACV is one of the most commonly developed oncolytic vectors. There are several features make VACV a promising oncolytic vector which include excellent lytic activity, natural and broad tumor tropism as well as well-known and easy-manipulating genome structure etc.

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Vaccinia Virus (VACV) Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Attenuated Vaccinia Virus
        1.2.3 Recombinant Vaccinia Virus
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Vaccinia Virus (VACV) Service Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Scientific Research
        1.3.3 Vaccine Development
        1.3.4 Oncolytic Therapy
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Vaccinia Virus (VACV) Service Market Perspective (2019-2030)
    2.2 Global Vaccinia Virus (VACV) Service Growth Trends by Region
        2.2.1 Global Vaccinia Virus (VACV) Service Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Vaccinia Virus (VACV) Service Historic Market Size by Region (2019-2024)
        2.2.3 Vaccinia Virus (VACV) Service Forecasted Market Size by Region (2025-2030)
    2.3 Vaccinia Virus (VACV) Service Market Dynamics
        2.3.1 Vaccinia Virus (VACV) Service Industry Trends
        2.3.2 Vaccinia Virus (VACV) Service Market Drivers
        2.3.3 Vaccinia Virus (VACV) Service Market Challenges
        2.3.4 Vaccinia Virus (VACV) Service Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Vaccinia Virus (VACV) Service Players by Revenue
        3.1.1 Global Top Vaccinia Virus (VACV) Service Players by Revenue (2019-2024)
        3.1.2 Global Vaccinia Virus (VACV) Service Revenue Market Share by Players (2019-2024)
    3.2 Global Vaccinia Virus (VACV) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players Ranking by Vaccinia Virus (VACV) Service Revenue
    3.4 Global Vaccinia Virus (VACV) Service Market Concentration Ratio
        3.4.1 Global Vaccinia Virus (VACV) Service Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Vaccinia Virus (VACV) Service Revenue in 2023
    3.5 Global Key Players of Vaccinia Virus (VACV) Service Head office and Area Served
    3.6 Global Key Players of Vaccinia Virus (VACV) Service, Product and Application
    3.7 Global Key Players of Vaccinia Virus (VACV) Service, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Vaccinia Virus (VACV) Service Breakdown Data by Type
    4.1 Global Vaccinia Virus (VACV) Service Historic Market Size by Type (2019-2024)
    4.2 Global Vaccinia Virus (VACV) Service Forecasted Market Size by Type (2025-2030)

 5 Vaccinia Virus (VACV) Service Breakdown Data by Application
    5.1 Global Vaccinia Virus (VACV) Service Historic Market Size by Application (2019-2024)
    5.2 Global Vaccinia Virus (VACV) Service Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Vaccinia Virus (VACV) Service Market Size (2019-2030)
    6.2 North America Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America Vaccinia Virus (VACV) Service Market Size by Country (2019-2024)
    6.4 North America Vaccinia Virus (VACV) Service Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Vaccinia Virus (VACV) Service Market Size (2019-2030)
    7.2 Europe Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe Vaccinia Virus (VACV) Service Market Size by Country (2019-2024)
    7.4 Europe Vaccinia Virus (VACV) Service Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Vaccinia Virus (VACV) Service Market Size (2019-2030)
    8.2 Asia-Pacific Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2019-2024)
    8.4 Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Vaccinia Virus (VACV) Service Market Size (2019-2030)
    9.2 Latin America Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America Vaccinia Virus (VACV) Service Market Size by Country (2019-2024)
    9.4 Latin America Vaccinia Virus (VACV) Service Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Vaccinia Virus (VACV) Service Market Size (2019-2030)
    10.2 Middle East & Africa Vaccinia Virus (VACV) Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2019-2024)
    10.4 Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 VectorBuilder
        11.1.1 VectorBuilder Company Details
        11.1.2 VectorBuilder Business Overview
        11.1.3 VectorBuilder Vaccinia Virus (VACV) Service Introduction
        11.1.4 VectorBuilder Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)
        11.1.5 VectorBuilder Recent Development
    11.2 Creative Biolabs
        11.2.1 Creative Biolabs Company Details
        11.2.2 Creative Biolabs Business Overview
        11.2.3 Creative Biolabs Vaccinia Virus (VACV) Service Introduction
        11.2.4 Creative Biolabs Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)
        11.2.5 Creative Biolabs Recent Development
    11.3 Creative Biogene
        11.3.1 Creative Biogene Company Details
        11.3.2 Creative Biogene Business Overview
        11.3.3 Creative Biogene Vaccinia Virus (VACV) Service Introduction
        11.3.4 Creative Biogene Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)
        11.3.5 Creative Biogene Recent Development
    11.4 Genevoyager (Wuhan) Co., Ltd.
        11.4.1 Genevoyager (Wuhan) Co., Ltd. Company Details
        11.4.2 Genevoyager (Wuhan) Co., Ltd. Business Overview
        11.4.3 Genevoyager (Wuhan) Co., Ltd. Vaccinia Virus (VACV) Service Introduction
        11.4.4 Genevoyager (Wuhan) Co., Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)
        11.4.5 Genevoyager (Wuhan) Co., Ltd. Recent Development
    11.5 Esco Aster Pte. Ltd.
        11.5.1 Esco Aster Pte. Ltd. Company Details
        11.5.2 Esco Aster Pte. Ltd. Business Overview
        11.5.3 Esco Aster Pte. Ltd. Vaccinia Virus (VACV) Service Introduction
        11.5.4 Esco Aster Pte. Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)
        11.5.5 Esco Aster Pte. Ltd. Recent Development
    11.6 Sementis
        11.6.1 Sementis Company Details
        11.6.2 Sementis Business Overview
        11.6.3 Sementis Vaccinia Virus (VACV) Service Introduction
        11.6.4 Sementis Revenue in Vaccinia Virus (VACV) Service Business (2019-2024)
        11.6.5 Sementis Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Vaccinia Virus (VACV) Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Attenuated Vaccinia Virus
 Table 3. Key Players of Recombinant Vaccinia Virus
 Table 4. Key Players of Other
 Table 5. Global Vaccinia Virus (VACV) Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Vaccinia Virus (VACV) Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Vaccinia Virus (VACV) Service Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Vaccinia Virus (VACV) Service Market Share by Region (2019-2024)
 Table 9. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Vaccinia Virus (VACV) Service Market Share by Region (2025-2030)
 Table 11. Vaccinia Virus (VACV) Service Market Trends
 Table 12. Vaccinia Virus (VACV) Service Market Drivers
 Table 13. Vaccinia Virus (VACV) Service Market Challenges
 Table 14. Vaccinia Virus (VACV) Service Market Restraints
 Table 15. Global Vaccinia Virus (VACV) Service Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Vaccinia Virus (VACV) Service Market Share by Players (2019-2024)
 Table 17. Global Top Vaccinia Virus (VACV) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccinia Virus (VACV) Service as of 2023)
 Table 18. Ranking of Global Top Vaccinia Virus (VACV) Service Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Vaccinia Virus (VACV) Service Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Vaccinia Virus (VACV) Service, Headquarters and Area Served
 Table 21. Global Key Players of Vaccinia Virus (VACV) Service, Product and Application
 Table 22. Global Key Players of Vaccinia Virus (VACV) Service, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Vaccinia Virus (VACV) Service Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Vaccinia Virus (VACV) Service Revenue Market Share by Type (2019-2024)
 Table 26. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Vaccinia Virus (VACV) Service Revenue Market Share by Type (2025-2030)
 Table 28. Global Vaccinia Virus (VACV) Service Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Vaccinia Virus (VACV) Service Revenue Market Share by Application (2019-2024)
 Table 30. Global Vaccinia Virus (VACV) Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Vaccinia Virus (VACV) Service Revenue Market Share by Application (2025-2030)
 Table 32. North America Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Vaccinia Virus (VACV) Service Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Vaccinia Virus (VACV) Service Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Vaccinia Virus (VACV) Service Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Vaccinia Virus (VACV) Service Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Vaccinia Virus (VACV) Service Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Vaccinia Virus (VACV) Service Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Vaccinia Virus (VACV) Service Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Vaccinia Virus (VACV) Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Vaccinia Virus (VACV) Service Market Size by Country (2025-2030) & (US$ Million)
 Table 47. VectorBuilder Company Details
 Table 48. VectorBuilder Business Overview
 Table 49. VectorBuilder Vaccinia Virus (VACV) Service Product
 Table 50. VectorBuilder Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)
 Table 51. VectorBuilder Recent Development
 Table 52. Creative Biolabs Company Details
 Table 53. Creative Biolabs Business Overview
 Table 54. Creative Biolabs Vaccinia Virus (VACV) Service Product
 Table 55. Creative Biolabs Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)
 Table 56. Creative Biolabs Recent Development
 Table 57. Creative Biogene Company Details
 Table 58. Creative Biogene Business Overview
 Table 59. Creative Biogene Vaccinia Virus (VACV) Service Product
 Table 60. Creative Biogene Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)
 Table 61. Creative Biogene Recent Development
 Table 62. Genevoyager (Wuhan) Co., Ltd. Company Details
 Table 63. Genevoyager (Wuhan) Co., Ltd. Business Overview
 Table 64. Genevoyager (Wuhan) Co., Ltd. Vaccinia Virus (VACV) Service Product
 Table 65. Genevoyager (Wuhan) Co., Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)
 Table 66. Genevoyager (Wuhan) Co., Ltd. Recent Development
 Table 67. Esco Aster Pte. Ltd. Company Details
 Table 68. Esco Aster Pte. Ltd. Business Overview
 Table 69. Esco Aster Pte. Ltd. Vaccinia Virus (VACV) Service Product
 Table 70. Esco Aster Pte. Ltd. Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)
 Table 71. Esco Aster Pte. Ltd. Recent Development
 Table 72. Sementis Company Details
 Table 73. Sementis Business Overview
 Table 74. Sementis Vaccinia Virus (VACV) Service Product
 Table 75. Sementis Revenue in Vaccinia Virus (VACV) Service Business (2019-2024) & (US$ Million)
 Table 76. Sementis Recent Development
 Table 77. Research Programs/Design for This Report
 Table 78. Key Data Information from Secondary Sources
 Table 79. Key Data Information from Primary Sources
 Table 80. Authors List of This Report


List of Figures
 Figure 1. Vaccinia Virus (VACV) Service Picture
 Figure 2. Global Vaccinia Virus (VACV) Service Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Vaccinia Virus (VACV) Service Market Share by Type: 2023 VS 2030
 Figure 4. Attenuated Vaccinia Virus Features
 Figure 5. Recombinant Vaccinia Virus Features
 Figure 6. Other Features
 Figure 7. Global Vaccinia Virus (VACV) Service Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Vaccinia Virus (VACV) Service Market Share by Application: 2023 VS 2030
 Figure 9. Scientific Research Case Studies
 Figure 10. Vaccine Development Case Studies
 Figure 11. Oncolytic Therapy Case Studies
 Figure 12. Vaccinia Virus (VACV) Service Report Years Considered
 Figure 13. Global Vaccinia Virus (VACV) Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Vaccinia Virus (VACV) Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Vaccinia Virus (VACV) Service Market Share by Region: 2023 VS 2030
 Figure 16. Global Vaccinia Virus (VACV) Service Market Share by Players in 2023
 Figure 17. Global Top Vaccinia Virus (VACV) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccinia Virus (VACV) Service as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Vaccinia Virus (VACV) Service Revenue in 2023
 Figure 19. North America Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Vaccinia Virus (VACV) Service Market Share by Country (2019-2030)
 Figure 21. United States Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Vaccinia Virus (VACV) Service Market Share by Country (2019-2030)
 Figure 25. Germany Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Vaccinia Virus (VACV) Service Market Share by Region (2019-2030)
 Figure 33. China Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Vaccinia Virus (VACV) Service Market Share by Country (2019-2030)
 Figure 41. Mexico Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Vaccinia Virus (VACV) Service Market Share by Country (2019-2030)
 Figure 45. Turkey Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Vaccinia Virus (VACV) Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. VectorBuilder Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)
 Figure 49. Creative Biolabs Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)
 Figure 50. Creative Biogene Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)
 Figure 51. Genevoyager (Wuhan) Co., Ltd. Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)
 Figure 52. Esco Aster Pte. Ltd. Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)
 Figure 53. Sementis Revenue Growth Rate in Vaccinia Virus (VACV) Service Business (2019-2024)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed

Vaccinia virus (VACV or VV) is the most widely used viral vector for the study of exogenous gene expression and immunogenicity of the resulting protein. Replication-competent recombinant VACV-based vaccines have received increasing attention as potential vaccine vectors for many infectious diseases, as they may be able to elicit potent humoral and cell-mediated immune responses and long-lasting protection.Vaccinia virus (VACV) is a large enveloped, double-stranded DNA virus in the genus of Orthopoxvirus of the family Poxviridae. The VACV genome is comprised of approximately 190,000 nucleotides which encodes approximately 250 genes. VACV is one of the most commonly developed oncolytic vectors. There are several features make VACV a promising oncolytic vector which include excellent lytic activity, natural and broad tumor tropism as well as well-known and easy-manipulating genome structure etc.